Oliver Wyman August 13, 2024
Healthcare leaders are optimistic about the use of AI. They must be strategic about navigating technical, operational, and regulatory challenges.
The buzz around artificial intelligence has reached fever pitch. In an Oliver Wyman-New York Stock Exchange Survey of executives from NYSE-listed companies, 96% said they viewed AI as an opportunity for their business, not a risk. Drilling down to respondents from health and life sciences companies, 100% ranked AI as an opportunity.
Healthcare respondents were especially optimistic about AI’s potential to improve workforce productivity (88%) and operational efficiency (75%). Most of those gains are likely to come through automation of burdensome manual tasks, but there are also upsides on the clinical front, ranging from bolstering diagnostic capabilities to delivering personalized...
Today's Sponsors
Today's Sponsor